Authors: GALLIGIONI E CETTO G NASCIMBEN O BUONADAONA A CRIVELLARI D MOLINO A VERONESI A GRAIFF C BARNI S PUCCETTI C FERRAZZI E RECALDIN E SAVA C SARACCHINI S SACCO C

Citation: E. Galligioni et al., HIGH-DOSE EPIRUBICIN AND CYCLOPHOSPHAMIDE (EC) VS CYCLOPHOSPHAMIDE, METHOTREXATE, FLUOROURACIL (CMF) AS ADJUVANT CHEMOTHERAPY IN HIGH-RISK PREMENOPAUSAL BREAST-CANCER PATIENTS (PTS) - A PROSPECTIVE RANDOMIZED TRIAL, European journal of cancer, 34, 1998, pp. 84-84

Authors: TUMMARELLO D MARI D GRAZIANO F ISIDORI P CETTO G PASINI F SANTO A CELLERINO R

Citation: D. Tummarello et al., A RANDOMIZED, CONTROLLED PHASE-III STUDY OF CYCLOPHOSPHAMIDE, DOXORUBICIN, AND VINCRISTINE WITH ETOPOSIDE (CAV-E) OR TENIPOSIDE (CAV-T), FOLLOWED BY RECOMBINANT INTERFERON-ALPHA MAINTENANCE THERAPY OR OBSERVATION, IN SMALL-CELL LUNG-CARCINOMA PATIENTS WITH COMPLETE RESPONSES, Cancer, 80(12), 1997, pp. 2222-2229

Authors: TUMMARELLO D GRAZIANO F ISIDORI P SANTO A CETTO G FEDELI A ROSSI G CELLERINO R

Citation: D. Tummarello et al., CONSOLIDATION BIOCHEMOTHERAPY FOR PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CARCINOMA RESPONDING TO INDUCTION PVM (CISPLATIN, VINBLASTINE, MITOMYCIN-C) REGIMEN - A PHASE-II STUDY, Cancer, 77(11), 1996, pp. 2251-2257

Authors: TUMMARELLO D GRAZIANO F MARI D CETTO G PASINI F ANTONIO S ISIDORI P GASPARINI S

Citation: D. Tummarello et al., SMALL-CELL LUNG-CANCER (SCLC) - A RANDOMIZED TRIAL OF CYCLOPHOSPHAMIDE, ADRIAMYCIN, VINCRISTINE PLUS ETOPOSIDE (CAV-E) OR TENIPOSIDE (CAV-T) AS INDUCTION TREATMENT, FOLLOWED IN COMPLETE RESPONDERS BY ALPHA-INTERFERON OR NO TREATMENT, AS MAINTENANCE THERAPY, Anticancer research, 14(5B), 1994, pp. 2221-2227